Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/12/2012WO2012047580A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
04/12/2012WO2012047538A1 Benzimidazole derivatives as pi3 kinase inhibitors
04/12/2012WO2012047495A2 Methods for preparing synthetic bile acids and compositions comprising the same
04/12/2012WO2012047487A1 2-pyridone antimicrobial compositions
04/12/2012WO2012047287A2 Upregulation of opioid receptors for pain management
04/12/2012WO2012047265A2 Improved adjuvant system for vaccine administration
04/12/2012WO2012047225A2 Methods of treating liver fibrosis and pre-cirrhosis with epidermal growth factor receptor inhibitors
04/12/2012WO2012047207A1 Compositions for treating chronic viral infections
04/12/2012WO2012047172A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
04/12/2012WO2012047171A1 Picropodophyllin polymorphs b or c for use in cancer therapy
04/12/2012WO2012047156A1 Isoxazol-3(2h)-one analogs as plasminogen inhibitors and their use in the treatment of fibrinolysis related diseases
04/12/2012WO2012047132A1 Interferon-inducing agent for the treatment of acute viral respiratory infections
04/12/2012WO2012047131A1 Anti-viral agent against influenza b
04/12/2012WO2012047017A2 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same
04/12/2012WO2012046945A2 Pharmaceutical and food composition for preventing or treating diabetes or obesity
04/12/2012WO2012046902A1 Method for treating parkinson's disease through the control of the vdac1 protein
04/12/2012WO2012046874A1 Method for evaluating degree of cancerization
04/12/2012WO2012046873A1 Method for evaluating degree of cancerization
04/12/2012WO2012046872A1 Method for evaluating degree of cancerization
04/12/2012WO2012046871A1 Method for evaluating degree of cancerization
04/12/2012WO2012046869A1 Cyclic amide derivative
04/12/2012WO2012046825A1 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer
04/12/2012WO2012046793A1 Novel jak3 inhibitor containing, as active ingredient, thiophene derivative having ureido group and aminocarbonyl group as substituents
04/12/2012WO2012046792A1 Gpr119 agonist
04/12/2012WO2012046772A1 Prophylactic and/or therapeutic agent against lymphedema
04/12/2012WO2012046771A1 Cycloalkane compound
04/12/2012WO2012046730A1 Method for activating helper t cell
04/12/2012WO2012046681A1 Agent for inhibiting expression of lipid metabolism related mrna
04/12/2012WO2012046653A1 Amine compound and use for same
04/12/2012WO2012046260A1 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
04/12/2012WO2012046249A1 Novel gpr 119 agonists
04/12/2012WO2012046207A1 Anti-parasitic substituted ring fused azine compounds
04/12/2012WO2012046193A1 New salt of a pyrimidin derivative
04/12/2012WO2012046145A2 Coriolus versicolor extracts, methods of preparation and uses thereof
04/12/2012WO2012046132A1 Quinazoline compounds as sodium channel blockers
04/12/2012WO2012046078A1 Novel composition
04/12/2012WO2012046050A1 Novel combinations
04/12/2012WO2012046047A1 Composition for use in the treatment of acne
04/12/2012WO2012046046A1 Composition for skin treatment
04/12/2012WO2012045999A1 Phosphoramidite derivatives of gemcitabine for use in the treatment cancer
04/12/2012WO2012045906A1 Polyhydroxylated aminocyclohexanes and use thereof for treating lysosomal diseases
04/12/2012WO2012045894A1 Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus
04/12/2012WO2012045883A1 Cyclopropylamine inhibitors of oxidases
04/12/2012WO2012045863A1 Pharmaceutical compositions comprising glimepiride and polyethylene glycol castor oil
04/12/2012WO2012045859A1 A pharmaceutical composition comprising a thiazolidinedione
04/12/2012WO2012045804A1 Hdac inhibitors to treat charcot-marie-tooth disease
04/12/2012WO2012045803A1 Co-crystals and salts of ccr3-inhibitors
04/12/2012WO2012045797A1 Lipothiophosphoramidates for gene delivery
04/12/2012WO2012045734A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides
04/12/2012WO2012045729A1 Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
04/12/2012WO2012045704A1 New treatments of hepatitis c virus infection
04/12/2012WO2012045451A1 Novel therapeutic treatment of progranulin-dependent diseases
04/12/2012WO2012045437A1 Methods for tumor treatment and adipogenesis differentiation
04/12/2012WO2012045363A1 Antidiabetic enolic glucoside of phenylpyruvic acid
04/12/2012WO2012045285A1 Pharmaceutical composition and application thereof
04/12/2012WO2012045283A1 Dalfampridine polymorph, preparation therefor, and application thereof
04/12/2012WO2012045282A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction
04/12/2012WO2012045280A1 Salts and polymorphs of sulfamide ns3 inhibitors
04/12/2012WO2012045237A1 Hsp90 inhibitor, preparation method and use thereof
04/12/2012WO2012045210A1 Pharmaceutical composition for treating septic shock and its use
04/12/2012WO2012045198A1 Use of polysaccharides from radix isatidis in manufacture of medicaments against influenza virus
04/12/2012WO2012045196A1 Phosphoglycerate kinase inhibitors
04/12/2012WO2012045195A1 Pyrrolopyrimidines as fak and alk inhibiters for treatment of cancers and other diseases
04/12/2012WO2012045194A1 Benzodiazepinones as fak inhibitors for treatment of cancer
04/12/2012WO2012045157A1 Arih2 regulates dendritic cell activation and autoimmunity
04/12/2012WO2012045124A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
04/12/2012WO2012045118A1 Combination therapy for the treatment of depression and other non-infectious diseases
04/12/2012WO2012045114A1 Agents and methods for treating hematologic conditions
04/12/2012WO2012031382A4 Special nutrient supplements for pregnant women
04/12/2012WO2012024584A3 Oxysterol compounds
04/12/2012WO2012024583A3 Oxysterol compounds
04/12/2012WO2012024581A3 Oxysterol compounds
04/12/2012WO2012024100A3 Process for preparing aminocyclohexyl ether compounds
04/12/2012WO2012022659A3 Synergistic activity of modulators of the no metabolism and of nadph oxidase in the sensitization of tumour cells
04/12/2012WO2012020123A3 Neuropilin as a biomarker for bevacizumab combination therapies
04/12/2012WO2012016845A3 Pharmaceutical formulation comprising a phosphodiesterase inhibitor
04/12/2012WO2012013713A3 Substituted imidazo[1,2-b]pyridazines
04/12/2012WO2012012339A3 Glycosylated acetaminophen pro-drug analogs
04/12/2012WO2012010641A3 Pharmaceutical composition for increasing cellular hypoxic tolerance
04/12/2012WO2012007906A3 Eudermic compositions
04/12/2012WO2012007345A3 Substituted imidazo[1,2-a]pyrimidines and -pyridines
04/12/2012WO2012006619A3 ANTIPARASITIC AGENTS BASED ON mTOR INHIBITORS
04/12/2012WO2012006397A3 Antiperspirant products comprising natural phospholipids and methods for manufacturing the same
04/12/2012WO2012006104A3 Compounds and methods for treating tuberculosis infection
04/12/2012WO2012006083A3 Targeted receptor-mediated sirna
04/12/2012WO2012006032A9 Treatment of blood cancer
04/12/2012WO2012004691A3 Pharmaceutical formulations of rasagiline
04/12/2012WO2012003421A9 Combinational compositions and methods for treatment of cancer
04/12/2012WO2012003370A3 Functional vascularization with biocompatible polysaccharide-based hydrogels
04/12/2012WO2012002644A3 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability
04/12/2012WO2012002640A3 Transdermal drug delivery system containing donepezil
04/12/2012WO2012001705A3 Pharmaceutical compositions of (r)-lansoprazole
04/12/2012WO2012001093A3 Liquid formulations of rupatadine fumarate
04/12/2012WO2011163499A3 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
04/12/2012WO2011163452A9 Treating surface of the eye disorders
04/12/2012WO2011163321A3 Composition and method of treating lipid encapsulated virus infections
04/12/2012WO2011160136A3 Progesterone containing oral dosage forms and related methods
04/12/2012WO2011160020A3 Carbapenem antibacterials with gram-negative activity
04/12/2012WO2011159974A3 TARGETING THE ALPHA3 SUBUNIT OF Na+K+-ATPase FOR THE TREATMENT OF COUGH WITH SULFENAMIDES
04/12/2012WO2011159945A9 Methods for treating neurological conditions
1 ... 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 ... 7860